Nova Leap Health Stock Market Value
| NVLPF Stock | USD 0.30 0.07 30.43% |
| Symbol | Nova |
Nova Leap 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Nova Leap's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Nova Leap.
| 12/01/2025 |
| 03/01/2026 |
If you would invest 0.00 in Nova Leap on December 1, 2025 and sell it all today you would earn a total of 0.00 from holding Nova Leap Health or generate 0.0% return on investment in Nova Leap over 90 days. Nova Leap is related to or competes with Guided Therapeutics, and Vaso Corp. Nova Leap Health Corp. provides home and home health care services in the United States and Canada More
Nova Leap Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Nova Leap's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Nova Leap Health upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 7.58 | |||
| Information Ratio | 0.0988 | |||
| Maximum Drawdown | 30.43 | |||
| Value At Risk | (4.35) | |||
| Potential Upside | 4.76 |
Nova Leap Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nova Leap's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Nova Leap's standard deviation. In reality, there are many statistical measures that can use Nova Leap historical prices to predict the future Nova Leap's volatility.| Risk Adjusted Performance | 0.0979 | |||
| Jensen Alpha | 0.6575 | |||
| Total Risk Alpha | 0.052 | |||
| Sortino Ratio | 0.0647 | |||
| Treynor Ratio | (0.53) |
Nova Leap March 1, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0979 | |||
| Market Risk Adjusted Performance | (0.52) | |||
| Mean Deviation | 2.21 | |||
| Semi Deviation | 2.11 | |||
| Downside Deviation | 7.58 | |||
| Coefficient Of Variation | 855.68 | |||
| Standard Deviation | 4.97 | |||
| Variance | 24.69 | |||
| Information Ratio | 0.0988 | |||
| Jensen Alpha | 0.6575 | |||
| Total Risk Alpha | 0.052 | |||
| Sortino Ratio | 0.0647 | |||
| Treynor Ratio | (0.53) | |||
| Maximum Drawdown | 30.43 | |||
| Value At Risk | (4.35) | |||
| Potential Upside | 4.76 | |||
| Downside Variance | 57.5 | |||
| Semi Variance | 4.45 | |||
| Expected Short fall | (9.69) | |||
| Skewness | 3.58 | |||
| Kurtosis | 20.92 |
Nova Leap Health Backtested Returns
Nova Leap appears to be out of control, given 3 months investment horizon. Nova Leap Health has Sharpe Ratio of 0.11, which conveys that the firm had a 0.11 % return per unit of risk over the last 3 months. By analyzing Nova Leap's technical indicators, you can evaluate if the expected return of 0.52% is justified by implied risk. Please exercise Nova Leap's Downside Deviation of 7.58, mean deviation of 2.21, and Risk Adjusted Performance of 0.0979 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Nova Leap holds a performance score of 8. The company secures a Beta (Market Risk) of -1.09, which conveys a somewhat significant risk relative to the market. As the market becomes more bullish, returns on owning Nova Leap are expected to decrease slowly. On the other hand, during market turmoil, Nova Leap is expected to outperform it slightly. Please check Nova Leap's potential upside and the relationship between the skewness and relative strength index , to make a quick decision on whether Nova Leap's current price movements will revert.
Auto-correlation | -0.53 |
Good reverse predictability
Nova Leap Health has good reverse predictability. Overlapping area represents the amount of predictability between Nova Leap time series from 1st of December 2025 to 15th of January 2026 and 15th of January 2026 to 1st of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Nova Leap Health price movement. The serial correlation of -0.53 indicates that about 53.0% of current Nova Leap price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.53 | |
| Spearman Rank Test | -0.61 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Nova OTC Stock
Nova Leap financial ratios help investors to determine whether Nova OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nova with respect to the benefits of owning Nova Leap security.